Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Tell Her Doc

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Tell Her Doc head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 224 · Grade C

Tell Her Doc

Visit Tell Her Doc Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Tell Her Doc a bad call — it's best for readers seeking several treatment formats who can confirm the selected prescription, clinical practice and upfront subscription charge. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
34
Supply Reliability
95
71
Transparency
90
80
Access Breadth
93
86
Clinical Oversight
92
76
Track Record
88
65
CoreAge RxBrief Score 94 · 67Tell Her Doc

Price, coverage & the tracker

CoreAge RxTell Her Doc
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the full selected plan

Compounded semaglutide offered; generic $269 start does not establish the drug, supplied period or full payment.

Introductory oral offers, injections and branded alternatives have separate conditions.

Full price details

Compounded semaglutide offered; current complete selected-plan quote unknown; generic GLP-1 starting figure $269 lacks a clear drug/period mapping; earlier listing: From $269/mo (microdose tier, plus a separate fee, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the full selected plan

Compounded tirzepatide offered; generic $269 start is not a confirmed separate tirzepatide quote.

Request medication, supplied weeks, upfront total and renewal terms.

Full price details

Compounded tirzepatide offered; current complete selected-plan quote unknown; generic GLP-1 starting figure $269 does not establish a separate tirzepatide total; earlier listing: Not disclosed

CoverageUS only; restrictions by state, confirmed at intakeHomepage advertises all fifty states; confirm the selected clinician, treatment and pharmacy are available for your physical location
Brand-name accessNot confirmedHomepage lists Ozempic and Zepbound as limited-stock alternatives; confirm current availability and their separate medication and care quotes.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Tell Her Doc: Generic GLP-1 start is $269; the page does not establish a full drug-specific period/renewal quote. Oral introduction and branded alternatives require separate terms.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.